Search CommunityWalk:


AuRx, Inc.

5331 Landing Road
Elkridge, MD 21075, USA

Category: Biotechnology/Biopharmaceutical - Vaccines

Used in the following map:

Maryland Biotech Industry Map

AuRx, Inc. is a biotechnology company that specializes in the treatment of long lasting and recurrent viral diseases.

AuRx's epidemiological studies have demonstrated that herpes viruses infect high proportions of population groups around the world. The company believes in the clinical data gained in the therapy of genital herpes will allow the company to effectively and efficiently design therapeutic vaccines for the relief of other long lasting viral diseases including HIV, Human Papilloma Virus, Epstein Barr Virus and Cytomegalovirus. Its AuRx herpes therapy works via cell-mediated immunity (CMI) and is based on facts that recurrent disease is associated with a preponderance of immune regulatory T cells [helper type 2 (Th2)] that function to downregulate the ability of the virus specific CMI to control virus replication. The AuRx therapy also reduces the production of the soluble mediator IL-10 which stimulates production of Th2 cells. It uses its recombinant technology to develop a rapid serological assay for HSV-2 which is based on the protein kinase of the large subunit of HSV-2 ribonucleotide reductase.

AuRx has alliance with Landsteiner Scientific, S.A. de C.V.